-
-
-
-
-
-
-
Sunovion Announces Health Canada Approval of KYNMOBI™ (apomorphine hydrochloride) Soluble Film for the Treatment of Parkinson’s Disease OFF Episodes
-
-
-
-
-
-
-
Urovant Sciences (UROV) Majority Shareholder, Roivant Sciences, and Sumitomo Dainippon Pharma Complete Transaction for Strategic Alliance
-
-
-
-
-
-
-
Urovant Sciences Secures Substantial Financial Commitment, Commercial Infrastructure Support and Minority Shareholder Protections from Sumitomo Dainippon Pharma Upon Close of Sumitomo Dainippon Pharma
-
-
-
-
-
-
-
Sunovion Announces Acceptance by the U.S. FDA of the New Drug Application for Dasotraline for the Treatment of Adults with Moderate-to-Severe Binge Eating Disorder
-
-
-
-
-
-
-
Sunovion Announces Health Canada Approval of Aptiom® (eslicarbazepine acetate) as Adjunctive Therapy for the Treatment of Partial-Onset Seizures in Adolescents and Children Above Six Years of Age
-
-
-
-
-
-
-
Sunovion Announces Data Presentations Highlighting Broad Portfolio of Treatments for COPD at the American Thoracic Society International Conference 2018
-
-
-
-
-
-
-
Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD
-
1,181,563 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

